Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial spread to 107 rural and urban Alberta emergency departments

OBJECTIVES: Opioid use disorder is a major public health concern that accounts for a high number of potential years of life lost. Buprenorphine/naloxone is a recommended treatment for opioid use disorder that can be started in the emergency department (ED). We developed an ED-based program to initia...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Kayla D., Scott, Ken, Holroyd, Brian R., Lang, Eddy, Yee, Karen, Taghizadeh, Niloofar, Deol, Janjeevan, Dong, Kathryn, Fanaeian, Josh, Ghosh, Monty, Low, Keysha, Ross, Marshall, Tanguay, Robert, Faris, Peter, Day, Nathaniel, McLane, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Quality Improvement and Patient Safety (QIPS)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225037/
https://www.ncbi.nlm.nih.gov/pubmed/37245202
http://dx.doi.org/10.1007/s43678-023-00520-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225037/
https://www.ncbi.nlm.nih.gov/pubmed/37245202
http://dx.doi.org/10.1007/s43678-023-00520-3

Ejemplares similares